The preventive effects of lifestyle intervention on the occurrence of diabetes mellitus and acute myocardial infarction in metabolic syndrome. (October 2016)

• Record Type: Journal Article
• Authors: Kim, D.; Yoon, S.-J.; Lim, D.-S.; Gong, Y.-H.; Ko, S.; Lee, Y.-H.; Lee, H.S.; Park, M.-S.; Kim, K.-H.; Kim, Y.A.
• Is Part Of: Public health. Volume 139(2016)
• Page Start: 178
• Page End: 182
• Publication Date: 2016-10
• Subjects: Metabolic syndrome -- Lifestyle intervention -- Diabetes mellitus -- Acute myocardial infarction; Public health -- Periodicals; Public health -- Periodicals; Electronic journals; 362.1
• DOI: 10.1016/j.puhe.2016.06.012
• Languages: English
• ISSNs: 0033-3506

Abstract

Abstract: Objectives: Metabolic syndrome (MS), as a precursor of diabetes mellitus (DM) and cardiovascular disease, is increasing steadily worldwide. We examined the preventive effects of lifestyle intervention on the occurrence of DM and acute myocardial infarction (AMI) in MS. Study design: Observational study on disease occurrence after lifestyle intervention. Methods: The lifestyle intervention was administered to subjects with MS participating in a metropolitan lifestyle intervention program for 1 year. The same numbers of non-participating age- and sex-matched subjects with MS were randomly extracted from national health examination data. After intervention or examination, new occurrences of hypertension, DM, and AMI were identified through the national health insurance claims data during 1 year. For DM and AMI, multivariate logistic regression analysis for the factors affecting each disease was performed. Results: In the intervention group and the control group (14, 918 in each group), the occurrence of hypertension was 555 (6.07%) and 751 (8.33%), the occurrence of DM was 324 (2.55%) and 488 (3.89%), the occurrence of dyslipidemia was 321 (2.59%) and 373 (2.72%), and the occurrence of AMI was 13 (0.09%) and 26 (0.17%), respectively. In multivariate logistic regression analysis, adjusted odds ratios for intervention were 0.752 (95% confidence interval [CI]: 0.644–0.879) and 0.499 (95% CI: 0.251–0.992) for DM and AMI, respectively, indicating that lifestyle intervention has a preventive effect. Conclusions: Lifestyle intervention in MS has preventive effects on the occurrence of DM and AMI, and long-term follow-up is needed to evaluate these preventive effects in more detail. Highlights: The lifestyle intervention was administered to subjects with metabolic syndrome (MS) participating in a lifestyle intervention program. The same number of non-participating age- and sex-matched subjects with MS were randomly extracted from national health examination data. The occurrence of diabetes mellitus and acute myocardial infarction was lower in the intervention group than in the control group. The lifestyle intervention is effective in lowering the occurrence of diabetes mellitus and acute myocardial infarction in metabolic syndrome.